Table 5

Univariate and multivariate analysis for early discharge post-TAVI

VariablesOR95% CIp ValueOR95% CIp Value
Baseline variables
 Prior PPM2.411.25 to 4.640.0082.801.36 to 5.750.005
 NYHA IV0.210.05 to 0.890.0340.220.05 to 0.960.045
 Prior BAV0.430.25 to 0.710.0010.630.33 to 1.030.063
 Female gender0.590.38 to 0.920.0190.650.41 to 1.040.075
 Age0.970.94 to 1.010.0660.980.95 to 1.010.216
 CRF*1.480.94 to 2.350.0931.170.70 to 1.960.556
 Permanent AF0.670.34 to 1.340.259 
 COPD0.960.60 to 1.540.872 
 PVD1.470.65 to 3.320.350 
 Prior LBBB0.490.17 to 0.460.202 
 Prior RBBB1.400.67 to 2.920.374 
Procedural variables
 CoreValve0.700.44 to 1.120.135 
 Device success0.960.54 to 1.710.879 
 PVR more than mild1.120.57 to 2.190.732 
 Major vascular complication0.200.05 to 0.850.029 
 Minor vascular complications1.000.46 to 2.180.996 
In-hospital variables
 Stroke or TIA1.340.26 to 7.030.726 
 Any bleeding2.691.12 to 6.460.0270.310.17 to 0.920.031
 New PPM0.470.23 to 0.950.0380.650.31 to 1.370.258
 Year of the procedure†1.340.26 to 7.030.7261.661.25 to 2.20<0.001
  • *Defined as GFR less than 60 mL/h.†Two-year period.

  • AF, atrial fibrillation; BAV, balloon aortic valvuloplasty; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; NYHA, New York Heart Association; LBBB, left bundle branch block; PPM, permanent pacemaker; PVD, peripheral vascular disease; PVR, paravalvular regurgitation; RBBB, right bundle branch block; TIA, transient ischaemic attack.